Sealonix develops a next‑generation hemostatic sealant patch for abdominopelvic surgeries, using its proprietary biomaterials that have a proven safety record across multiple medical specialties. The conformable, absorbable patch provides rapid bleeding control, aiming to reduce intra‑operative blood loss, shorten surgery time, and lower postoperative complications for surgeons and hospitals.
Funding
$20M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
4OEVFounders
Product
Problem
Current hemostatic agents often fail to provide reliable bleeding control in increasingly complex and lengthy surgeries, especially for frail patients with comorbidities. Ineffective bleeding management leads to longer operative times, higher material costs, and increased risk of postoperative complications and mortality.
Solution
Sealonix is developing a next‑generation hemostatic sealant patch that leverages the company’s proprietary biomaterials, which have a long history of safe use in cranial, spinal, urological, vascular, and ophthalmologic applications. The patch is designed for rapid hemostasis in abdominopelvic procedures, delivering a conformable, bio‑compatible barrier that seals bleeding tissue quickly and securely. By integrating a material platform already validated in over 10 million patients, the solution aims to reduce intra‑operative blood loss, shorten surgery duration, and lower the incidence of postoperative complications. The technology is positioned as an investigational device pending regulatory approval, with a focus on delivering consistent performance across a range of surgical contexts.
Target Audience
Primary customers are surgeons and hospitals performing abdominopelvic operations, including general, colorectal, and gynecologic surgery teams seeking more reliable bleeding control.
Features
- Proprietary biomaterial formulation with a proven safety record in multiple medical specialties
- Patch format that conforms to irregular tissue surfaces for immediate sealing of bleeding sites
- Rapid hemostatic action to minimize intra‑operative blood loss and operative time
- Biocompatible and absorbable composition that integrates with native tissue without leaving permanent foreign material
- Designed specifically for abdominopelvic surgeries, addressing the needs of high‑risk, comorbid patient populations